Free Trial

Lexeo Therapeutics (LXEO) SEC Filings & 10K Form

Lexeo Therapeutics logo
$6.11 -0.01 (-0.16%)
(As of 09:34 AM ET)

Recent Lexeo Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
4:49 PM
Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
Form SC 13G/A
11/14/2024
11:32 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/14/2024
11:23 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:31 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:33 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:34 PM
Lexeo Therapeutics (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:31 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:32 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/13/2024
6:33 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:35 AM
Lexeo Therapeutics (Filer)
Form 424B3
11/12/2024
8:31 AM
Adage Capital Management, L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G
10/30/2024
5:15 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
5:17 AM
Lexeo Therapeutics (Filer)
Form 424B3
10/15/2024
12:45 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:30 PM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:32 PM
Lexeo Therapeutics (Filer)
Form 424B3
09/11/2024
4:17 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:39 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
5:34 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:02 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:11 AM
Lexeo Therapeutics (Filer)
Form 424B3
08/09/2024
8:43 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
08/05/2024
11:54 AM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
07/15/2024
6:55 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
6:59 AM
Lexeo Therapeutics (Filer)
Form 424B3
07/12/2024
3:55 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
5:20 PM
Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
5:26 PM
Lexeo Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:01 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
6:04 AM
Lexeo Therapeutics (Filer)
Form 424B3
06/28/2024
6:33 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
6:36 AM
Lexeo Therapeutics (Filer)
Form 424B3
06/27/2024
4:01 PM
Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:01 PM
CHOLMONDELEY PAULA H (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:02 PM
DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:04 PM
Altschuler Steven (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:05 PM
COOPERSTONE BRENDA (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
8:04 AM
Lexeo Therapeutics (Issuer)
Otero Jose Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:04 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
4:14 PM
Lexeo Therapeutics (Subject)
Townsend Richard Nolan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]
05/09/2024
6:02 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:07 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:09 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/26/2024
6:55 AM
Lexeo Therapeutics (Filer)
Lexeo Therapeutics (Filer)
Form DEF 14A
04/26/2024
6:56 AM
Lexeo Therapeutics (Filer)
Form DEFA14A
04/26/2024
6:57 AM
Lexeo Therapeutics (Filer)
Form ARS
04/26/2024
6:57 AM
Lexeo Therapeutics (Filer)
Form ARS
04/22/2024
7:22 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
7:23 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/22/2024
7:24 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/22/2024
7:11 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
6:35 AM
Lexeo Therapeutics (Filer)
Form 424B3
04/16/2024
6:32 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2024
11:15 PM
Lexeo Therapeutics (Filer)
Form EFFECT
04/12/2024
4:04 PM
Lexeo Therapeutics (Filer)
Form 424B3
04/09/2024
7:01 AM
Lexeo Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/11/2024
8:29 AM
Lexeo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G/A
02/14/2024
3:43 PM
Lexeo Therapeutics (Subject)
Omega Fund VI, L.P. (Filed by)
Form SC 13G
02/14/2024
3:34 PM
Lexeo Therapeutics (Subject)
Lundbeckfond Invest A/S (Filed by)
Form SC 13G
02/14/2024
12:43 PM
JANUS HENDERSON GROUP PLC (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G
02/14/2024
5:04 AM
D1 Capital Partners L.P. (Filed by)
Lexeo Therapeutics (Subject)
Form SC 13G
02/06/2024
4:56 PM
Adler Eric (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
4:57 PM
Agger Mette Kirstine (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
4:58 PM
DIAZ REINALDO M (Reporting)
Lexeo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
4:58 PM
Lexeo Therapeutics (Issuer)
See Tai Sandi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2024
6:03 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
5:50 PM
Lexeo Therapeutics (Issuer)
Robertson Jenny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:52 PM
Lexeo Therapeutics (Issuer)
Townsend Richard Nolan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
6:00 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
3:51 PM
Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
Form SC 13G/A
12/11/2023
6:02 AM
Lexeo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/11/2023
6:03 AM
Lexeo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
3:33 PM
Lexeo Therapeutics (Subject)
Novo Holdings A/S (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LXEO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners